KIF12 and differentiated thyroid carcinoma: The results showed that the downregulation of KIF-12 expression enhances the progression of differentiated thyroid carcinoma, and the effect may be more significant among younger female patients with unifocal PTC showing lymph node metastasis and BRAF mutation.